<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: CpG island (CGI) hypermethylation at discrete loci is a prevalent <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-promoting abnormality in <z:hpo ids='HP_0003745'>sporadic</z:hpo> colorectal <z:mp ids='MP_0002038'>carcinomas</z:mp> (S-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated genome-wide CGI methylation in <z:e sem="disease" ids="C0021390" disease_type="Disease or Syndrome" abbrv="">inflammatory bowel disease</z:e> (IBD)-associated <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> (IBD-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e>) </plain></SENT>
<SENT sid="2" pm="."><plain>METHODS: Methylation microarray analyses were conducted on seven IBD-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e>, 17 S-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e>, and eight <z:mpath ids='MPATH_458'>normal</z:mpath> control colonic tissues from patients without <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> or IBD </plain></SENT>
<SENT sid="3" pm="."><plain>CGI methylator phenotype (CIMP), a surrogate marker for widespread <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e>-specific CGI hypermethylation, was examined in 30 IBD-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> and 43 S-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The genome-wide CGI methylation pattern of IBD-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> was CIMP status-dependent </plain></SENT>
<SENT sid="5" pm="."><plain>Based on methylation array data profiling of <z:hpo ids='HP_0000001'>all</z:hpo> autosomal loci, CIMP(+) IBD-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> grouped together with S-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e>, while CIMP(-) IBD-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> grouped together with control tissues </plain></SENT>
<SENT sid="6" pm="."><plain>CIMP(-) IBD-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> demonstrated less methylation than did age-matched CIMP(-) S-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> at autosomal CGIs (z-score -0.17 vs. 0.09, P = 3 �� 10(-3)) and <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>-associated hypermethylation target CGIs (z-score -0.43 vs. 0.68, P = 1 × 10(-4)) </plain></SENT>
<SENT sid="7" pm="."><plain>Age-associated hypermethylation target CGIs were significantly overrepresented in CGIs that were hypermethylated in S-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> (P = 1 × 10(-192)), but not in CGIs that were hypermethylated in IBD-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> (P = 0.11) </plain></SENT>
<SENT sid="8" pm="."><plain>In contrast, KRAS mutation prevalence was similar between IBD-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> and S-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Notably, CIMP(+) prevalence was significantly higher in older than in younger IBD-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cases (50.0 vs. 4.2, P = 0.02), but not in S-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> cases (9.7 vs. 16.7, P = 0.92) </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSIONS: <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">Cancer</z:e>-specific CGI hypermethylation and age-associated CGI hypermethylation are diminished in IBD-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> relative to S-<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e>, while the KRAS mutation rate is comparable between these <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="11" pm="."><plain>CGI hypermethylation appears to play only a minor role in IBD-associated <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain>We speculate that aging, rather than <z:mp ids='MP_0001845'>inflammation</z:mp> per se, promotes CIMP(+) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> in IBD patients </plain></SENT>
</text></document>